We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Smartphone-Based Device Used for Influenza Virus Detection

By LabMedica International staff writers
Posted on 05 Aug 2019
A simple and inexpensive smartphone-based device was able to detect influenza virus particles in clinical samples with almost 100 times greater sensitivity than commercial rapid influenza diagnostic tests.

Droplet-based digital bioassays enable highly sensitive and quantitative analysis of biomolecules. More...
However, digital bioassays generally require fluorescence microscopy techniques for detection, which are too large, expensive, and slow for point-of-care testing.

Investigators at the University of Tokyo (Japan) recently descibed an alternative method for detection of viruses in clinical samples. For this purpose, they developed a simple smartphone-based mobile imaging platform (23 × 10 cenitmeters × seven centimeters high) for digital point-of-care bioassays.

The device was designed to trap virus particles on a clear surface in microwells of 48 femtoliters capacity illuminated by an LED lamp. When a virus became trapped inside the microwell, the incident light from the LED was redirected upwards into the camera lens, manifesting as a bright pixel in an otherwise dark field.

The investigators used the smartphone device for digital influenza virus counting (DIViC) based on a fluorogenic assay for neuraminidase activity of the virus. Distinct fluorescence spots derived from single virus particles were observed. The number of detected fluorescence spots correlated well against the virus titer, suggesting that high sensitivity and quantification were achieved. On the other hand, the mobile platform detected only about 60% of influenza virus particles that could be identified by conventional fluorescence microscopy. Nonetheless, digital influenza virus counting with the mobile imaging platform still demonstrated 100 times greater sensitivity than could be obtained with a commercial rapid influenza test kit.

"I wanted to produce a useful tool for inaccessible or less-affluent communities that can help in the fight against diseases such as influenza," said first author Dr. Yoshihiro Minagawa, chief researcher in the faculty of engineering at the University of Tokyo. "Diagnosis is a critical factor of disease prevention. Our device paves the way for better access to essential diagnostic tools."

"Given two equal samples containing influenza, our system detected about 60% of the number of viruses as the fluorescence microscope. But it is much faster at doing so and more than adequate to produce good estimates for accurate diagnoses," said Dr. Minagawa. "What is really amazing is that our device is about 100 times more sensitive than a commercial rapid influenza test kit, and it is not just limited to that kind of virus. We also wish to add other biomarkers such as nucleic acids -- like DNA -- to the options of things the device can detect. This way we can maximize its usefulness to those on the front line of disease prevention, helping to save lives."

The smartphone-based virus detector was described in the July 17, 2019, online edition of the journal Lab on a Chip.

Related Links:
University of Tokyo


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: The innovative classifier can guide treatment for PDAC and other immunotherapy-resistant cancers (Photo courtesy of Adobe Stock))

Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.